Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The most effective method to Boost Benefits in Gold Speculation: Master Techniques and Tips - 2Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- 3Israel's haredi draft crisis: Court ruling and political stalemate reach breaking point
- 4Sophie Kinsella, 'Confessions of a Shopaholic' author, dies at 55 after battle with cancer
- 5The most effective method to Connect Successfully with Teachers in a Web based Setting
- Former GLP-1 users regain lost weight after about 18 months, study says
- EU Commission prepares €90bn Ukraine loan despite Hungary's veto
- An Ideal Getaway - Spots for Solo Travel
- Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers
- Find Unexpected, yet invaluable treasure Excursion Rentals
- The Effect of Online Organizations on Society: Beating the Difficulties
- How comfort foods trigger pleasure in our brains
- Who plays Moana in the live-action remake? What to know about Catherine Lagaʻaia.
- Figure out How to Plan for Your Web-based Degree monetarily
